Journal of Cancer Diagnosis
Open Access

Hematologic Malignancies: Advancing Precision Diagnostics, Therapies

Hannah Weiss^*

Austrian Medical Cancer Institute, Austria

Received Date: Sep 01, 2025 / Accepted Date: Sep 29, 2025 / Published Date: Sep 29, 2025

Citation: Weiss H (2025) Hematologic Malignancies: Advancing Precision Diagnostics, Therapies. jcd 09: 317.DOI: 10.4172/2476-2253.1000317

Copyright: © 2025 Hannah Weiss This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF

Hematologic malignancies are witnessing significant advancements across diagnostic and therapeutic spectrums. Novel ap
proaches include CAR T-cell therapy, precision medicine leveraging genomic and proteomic profiling, and sophisticated Next
Generation Sequencing for minimal residual disease detection. Research also highlights the critical roles of epigenetic mechanisms
and the bone marrowmicroenvironment as therapeutic targets. Improved diagnostic modalities, Allogeneic Hematopoietic Stem Cell
Transplantation, targeted therapies, and immunotherapies are reshaping patient care. Concurrently, managing infectious complica
tions remains a vital aspect of treatment, reflecting a holistic effort to enhance outcomes for these complex diseases.